Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Midazolam Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
04/02/2020
»Therapeutic Categories: Anesthesia; Neurology
Avet Pharmaceuticals, Inc. (Revised 09/03/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 5 mg/1 mL (NDC 23155-601-42) | Available | ||
| Injection, 5 mg/1 mL (NDC 23155-601-41) | Available | ||
| Injection, 1 mg/1 mL (NDC 23155-600-41) | Available |
Fresenius Kabi USA, LLC (Revised 09/04/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 1 mg/1 mL (NDC 63323-411-10) | Limited Availability | 3 & 6 mos dating available for wholesalers. Check wholesalers for inventory | Demand increase for the drug |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-001-20) | Available | Check wholesalers for inventory | |
| Injection, 1 mg/1 mL (NDC 63323-411-12) | Available | Check wholesalers for inventory | |
| Injection, 1 mg/1 mL (NDC 63323-411-25) | Available | Check wholesalers for inventory | |
| Injection, 5 mg/1 mL (NDC 63323-412-25) | Available | Check wholesalers for inventory | |
| Injection, 5 mg/1 mL (NDC 63323-412-10) | Available | Check wholesalers for inventory | |
| Injection, 5 mg/1 mL (NDC 63323-412-02) | Available | Check wholesalers for inventory |
Gland Pharma Limited (Revised 07/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 70860-601-10) | Available | ||
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 70860-601-05) | Available | ||
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 47781-589-17) | Unavailable | Demand increase for the drug | |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 47781-589-91) | Available | ||
| Midazolam Hydrochloride, Injection, 2 mg/2 mL (NDC 70860-600-02) | Available | ||
| Midazolam Hydrochloride, Injection, 2 mg/2 mL (NDC 47781-588-68) | Available |
Hikma Pharmaceuticals USA, Inc. (Reverified 08/28/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Midazolam Injection, USP, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Midazolam Injection, USP, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Midazolam Injection, USP, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Midazolam Injection, USP, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Available | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | |
| Midazolam Injection, USP, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Unavailable | Additional lots will be available in the September - October 2024 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Hospira, Inc., a Pfizer Company (Reverified 08/26/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) | Available | ||
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Available | ||
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Available | ||
| Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Unavailable | Next Delivery: July 2026; Estimated Recovery: September 2026 | Demand increase for the drug |
| Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Available | ||
| Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Available | ||
| Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Available |
WG Critical Care (Reverified 09/01/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | Available | Please check wholesalers and distributors for inventory. | |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | Available | Please check wholesalers and distributors for inventory. |